Pfizer to buy 8.1% stake in vaccines company Valneva
US healthcare giant Pfizer has agreed to invest €90.5 million to buy an 8.1% percent stake in French vaccines company, as the companies announced developments in their partnership to tackle Lyme disease.
Business
• 20 Jun 22
